相似文献
1
Examining the paradox of high high-density lipoprotein and elevated cardiovascular risk.探讨高密度脂蛋白水平高与心血管风险升高这一矛盾现象。
J Thorac Dis. 2018 Jan;10(1):109-112. doi: 10.21037/jtd.2017.12.97.
2
Elevated concentrations of high-density lipoprotein cholesterol and cardiovascular risk paradox in patients with coronary heart disease and the equivalents.冠心病及相关病症患者中高密度脂蛋白胆固醇浓度升高与心血管风险悖论
Int J Cardiol. 2014 Oct 20;176(3):1316-7. doi: 10.1016/j.ijcard.2014.07.153. Epub 2014 Aug 2.
3
Lipid paradox in acute myocardial infarction-the association with 30-day in-hospital mortality.急性心肌梗死中的脂质悖论——与30天院内死亡率的关联
Crit Care Med. 2015 Jun;43(6):1255-64. doi: 10.1097/CCM.0000000000000946.
4
Managing dyslipidemia in primary care with restricted access to lipid-modifying therapy.在基层医疗中管理血脂异常，同时获取脂质调节治疗的机会有限。
Am Health Drug Benefits. 2010 Sep;3(5):340-9.
5
Low high-density lipoprotein cholesterol disorders and cardiovascular risk: contribution of associated low-density lipoprotein subclass abnormalities.低高密度脂蛋白胆固醇紊乱与心血管风险：相关低密度脂蛋白亚类异常的作用
Curr Opin Cardiol. 2005 Jul;20(4):313-7. doi: 10.1097/01.hco.0000168534.15085.5d.
6
Role of non-high-density lipoprotein cholesterol in prevention of cardiovascular disease: updated evidence from clinical trials.非高密度脂蛋白胆固醇在预防心血管疾病中的作用：来自临床试验的最新证据。
Curr Opin Cardiol. 2003 Nov;18(6):503-9. doi: 10.1097/00001573-200311000-00012.
7
The predictive study of the relation between elevated low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality in peritoneal dialysis.低密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值升高与腹膜透析患者死亡率的预测研究。
Lipids Health Dis. 2020 Mar 21;19(1):51. doi: 10.1186/s12944-020-01240-8.
8
Is lipoprotein(a) measurement important for cardiovascular risk stratification in children and adolescents?脂蛋白(a)测量在儿童和青少年心血管风险分层中的重要性如何？
Ital J Pediatr. 2024 Sep 4;50(1):161. doi: 10.1186/s13052-024-01732-8.
9
U-Shaped Association of High-Density Lipoprotein Cholesterol with All-Cause and Cardiovascular Mortality in Hypertensive Population.高血压人群中高密度脂蛋白胆固醇与全因死亡率和心血管死亡率的U型关联
Risk Manag Healthc Policy. 2020 Oct 8;13:2013-2025. doi: 10.2147/RMHP.S272624. eCollection 2020.
10
Non-high-density lipoprotein (non-HDL) cholesterol in adolescence as a predictor of atherosclerotic cardiovascular diseases in adulthood.青少年时期的非高密度脂蛋白（non-HDL）胆固醇可预测成年后动脉粥样硬化性心血管疾病。
Rev Cardiovasc Med. 2021 Jun 30;22(2):295-299. doi: 10.31083/j.rcm2202037.
引用本文的文献
1
High-density lipoproteins, Part 1. Epidemiology, antiatherogenic effects, and therapies designed to increase their serum levels.高密度脂蛋白，第1部分。流行病学、抗动脉粥样硬化作用以及旨在提高其血清水平的治疗方法。
Am J Prev Cardiol. 2025 Jul 21;23:101068. doi: 10.1016/j.ajpc.2025.101068. eCollection 2025 Sep.
2
Mendelian randomization analyses clarify the effects of height on cardiovascular diseases.孟德尔随机化分析阐明了身高对心血管疾病的影响。
PLoS One. 2024 Jul 3;19(7):e0298786. doi: 10.1371/journal.pone.0298786. eCollection 2024.
3
The Association Between Lipid Profile and Subfoveal Choroidal Thickness in Chinese Patients with Proliferative Diabetic Retinopathy Secondary to Type 2 Diabetes.2型糖尿病继发增殖性糖尿病视网膜病变中国患者的血脂谱与黄斑中心凹下脉络膜厚度之间的关联
Diabetes Metab Syndr Obes. 2023 Aug 17;16:2477-2489. doi: 10.2147/DMSO.S419794. eCollection 2023.
4
The association between HDL-C and stroke in the middle-aged and elderly: A cross-sectional study.载脂蛋白 B 与高密度脂蛋白胆固醇比值对老年女性冠状动脉粥样硬化斑块的预测价值
高密度脂蛋白胆固醇与中年和老年人中风的关联：一项横断面研究。
Brain Behav. 2023 Mar;13(3):e2901. doi: 10.1002/brb3.2901. Epub 2023 Feb 7.
5
HDL Is Not Dead Yet.高密度脂蛋白尚未“死亡”。
Biomedicines. 2022 Jan 7;10(1):128. doi: 10.3390/biomedicines10010128.
6
Is a High HDL-Cholesterol Level Always Beneficial?高HDL胆固醇水平总是有益的吗？
Biomedicines. 2021 Aug 25;9(9):1083. doi: 10.3390/biomedicines9091083.
7
The significances and clinical implications of cholesterol components in human breast cancer.人类乳腺癌中胆固醇成分的意义和临床意义。
Sci Prog. 2021 Jul-Sep;104(3):368504211028395. doi: 10.1177/00368504211028395.
8
HDL in Atherosclerotic Cardiovascular Disease: In Search of a Role.载脂蛋白高密度脂蛋白在动脉粥样硬化性心血管疾病中的作用：探寻新的可能。
Cells. 2021 Jul 23;10(8):1869. doi: 10.3390/cells10081869.
9
Prevalence of High HDL Cholesterol and Its Associated Factors Among Tunisian Women of Childbearing Age: A Cross-Sectional Study.生育年龄的突尼斯妇女中高 HDL 胆固醇的流行情况及其相关因素：一项横断面研究。
Int J Environ Res Public Health. 2021 May 20;18(10):5461. doi: 10.3390/ijerph18105461.
10
Association between extremely high high-density lipoprotein-cholesterol and hypertensive retinopathy: results of a cross-sectional study from Kanagawa Investigation of Total Checkup Data from the National Database-6 (KITCHEN-6).极高高密度脂蛋白胆固醇与高血压性视网膜病变的关联：来自全国数据库-6（KITCHEN-6）的横断面研究结果。
BMJ Open. 2021 May 11;11(5):e043677. doi: 10.1136/bmjopen-2020-043677.
本文引用的文献
1
Association of CETP Gene Variants With Risk for Vascular and Nonvascular Diseases Among Chinese Adults.载脂蛋白 E 基因多态性与中国成年人血管和非血管疾病风险的关联。
JAMA Cardiol. 2018 Jan 1;3(1):34-43. doi: 10.1001/jamacardio.2017.4177.
2
Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart Disease.胆固醇酯转运蛋白基因的蛋白质截短变异与冠心病风险
Circ Res. 2017 Jun 23;121(1):81-88. doi: 10.1161/CIRCRESAHA.117.311145. Epub 2017 May 15.
3
Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies.极高的高密度脂蛋白胆固醇水平与男性和女性的高死亡率呈矛盾关系：两项前瞻性队列研究。
Eur Heart J. 2017 Aug 21;38(32):2478-2486. doi: 10.1093/eurheartj/ehx163.
4
Beyond Coronary Calcification, Family History, and C-Reactive Protein: Cholesterol Efflux Capacity and Cardiovascular Risk Prediction.超越冠状动脉钙化、家族病史和C反应蛋白：胆固醇流出能力与心血管风险预测
J Am Coll Cardiol. 2016 May 31;67(21):2480-7. doi: 10.1016/j.jacc.2016.03.538.
5
Modulating cholesterol efflux capacity to improve cardiovascular disease.调节胆固醇流出能力以改善心血管疾病。
Curr Opin Lipidol. 2016 Aug;27(4):398-407. doi: 10.1097/MOL.0000000000000317.
6
Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease.清道夫受体BI中的罕见变异会升高高密度脂蛋白胆固醇并增加冠心病风险。
Science. 2016 Mar 11;351(6278):1166-71. doi: 10.1126/science.aad3517.
7
Cholesterol Efflux Capacity as a Therapeutic Target: Rationale and Clinical Implications.胆固醇流出能力作为治疗靶点：理论依据及临床意义
J Am Coll Cardiol. 2015 Nov 17;66(20):2211-2213. doi: 10.1016/j.jacc.2015.09.012.
8
Relation of black race between high density lipoprotein cholesterol content, high density lipoprotein particles and coronary events (from the Dallas Heart Study).黑人种族中高密度脂蛋白胆固醇含量、高密度脂蛋白颗粒与冠状动脉事件的关系（来自达拉斯心脏研究）
Am J Cardiol. 2015 Apr 1;115(7):890-4. doi: 10.1016/j.amjcard.2015.01.015. Epub 2015 Jan 15.
9
Coronary heart disease risks associated with high levels of HDL cholesterol.与高水平高密度脂蛋白胆固醇相关的冠心病风险。
J Am Heart Assoc. 2014 Mar 13;3(2):e000519. doi: 10.1161/JAHA.113.000519.
10
The addition of niacin to statin therapy improves high-density lipoprotein cholesterol levels but not metrics of functionality.在他汀类药物治疗中添加烟酸可改善高密度脂蛋白胆固醇水平，但不能改善功能指标。
J Am Coll Cardiol. 2013 Nov 12;62(20):1909-10. doi: 10.1016/j.jacc.2013.07.025. Epub 2013 Aug 7.
Zotero 插件